Immunotherapeutic interventions of Triple Negative Breast Cancer

Area of Science:

• Oncology
• Immunology
• Cancer Therapeutics

Background:

• Triple Negative Breast Cancer (TNBC) is a heterogeneous subtype lacking key receptors, leading to poorer outcomes despite chemotherapy sensitivity.
• TNBC remains a leading cause of cancer mortality in women due to its aggressive nature and limited targeted treatment options.

Purpose of the Study:

• To review the current landscape and future potential of immunotherapy for Triple Negative Breast Cancer (TNBC).
• To explore novel therapeutic strategies, including immune checkpoint inhibitors, adoptive cell therapy, and cancer vaccines, in the context of TNBC.
• To examine the interplay between different therapies and emerging agents like antibody-drug conjugates and exosomes.

Main Methods:

• Comprehensive literature review focusing on tumor microenvironment, host immunity, and clinical treatments for TNBC.
• Analysis of recent advancements in immunotherapy, including immune checkpoint inhibitors, targeted treatments, adoptive cell therapy, and cancer vaccines.
• Evaluation of synergistic effects of combined therapies, such as immunotherapy with chemotherapy, antibody-drug conjugates, and exosomes.

Main Results:

• Immunotherapy is emerging as a promising treatment option for TNBC, driven by the identification of TNBC-specific antigens and advancements in antibody and vaccine technology.
• Combination strategies, including immune checkpoint inhibitors with targeted treatments, show potential for enhanced efficacy.
• Emerging agents like antibody-drug conjugates and exosomes demonstrate potential as multifunctional therapeutic agents.

Conclusions:

• Immunotherapy offers a novel and promising avenue for treating Triple Negative Breast Cancer (TNBC).
• Combination therapies and novel agents like antibody-drug conjugates and exosomes hold significant potential for improving TNBC patient outcomes.
• Further research into the synergistic effects and interplay of these therapies is crucial for advancing TNBC treatment.